Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
A pediatric adverse-event database analysis found disproportionate reporting of psychotic symptoms with several antibiotics relative to minocycline. Presented at a conference, the findings identify a safety signal but do not establish causation or incidence.
Child & Adolescent Psychiatry November 10th 2026
MDLinx
A scenario-based article examines an alprazolam request from a patient anticipating election-night anxiety, alcohol use, and possible zolpidem exposure. It emphasizes individualized assessment and communication, without reporting outcomes or establishing a universal prescribing rule.
Family Medicine/General Practice November 10th 2026
Medical Xpress
A randomized trial found greater symptom improvement with single-dose intranasal mebufotenin than with a low-dose control in treatment-resistant depression. Most higher-dose recipients met discharge criteria within two hours; longer-term outcomes remain uncertain.
Psychiatry November 10th 2026
Psychiatrist.com
An expert panel reviewing two network meta-analyses found favorable efficacy rankings for adjunctive lumateperone in major depression, alongside higher discontinuation risks. The indirect comparisons do not establish superiority over other agents.
News Medical
In mice, psilocybin accelerated dendritic spine formation and maturation, with different remodeling patterns in stressed and healthy brains. Genetic experiments separated these structural effects from head-twitch behavior, a proxy rather than a direct measure of hallucinations.
Clinical Pharmacology November 10th 2026
Australian adolescents who reported eating more fruit and drinking fewer sugar-sweetened beverages were less likely to cross depression or anxiety screening thresholds over three years, although the observational findings did not establish causality.
Adolescent Medicine November 5th 2026